TC2N-TRIP11 Fusion FISH Probe
The TC2N-TRIP11 Fusion FISH Probe is used to confirm a fusion of the TC2N and TRIP11 genes. The fusion of the TC2N and TRIP11 genes has been associated with Liver Hepatocellular Carcinoma, and Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TC2N-TRIP11-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TC2N-TRIP11-20-AQAQ | 20 (40 μL) | 200 μL |
|
TRIP11 Gene Summary
This gene was identified based on the interaction of its protein product with thyroid hormone receptor beta. This protein is associated with the Golgi apparatus. The N-terminal region of the protein binds Golgi membranes and the C-terminal region binds the minus ends of microtubules; thus, the protein is thought to play a role in assembly and maintenance of the Golgi ribbon structure around the centrosome. Mutations in this gene cause achondrogenesis type IA.[provided by RefSeq, Mar 2010]
Gene Name: Thyroid Hormone Receptor Interactor 11
Chromosome: CHR14: 92434242 -92506403
Locus: 14q32.12
TC2N Gene Summary
The Tandem C2 Domains, Nuclear (TC2N) gene is located on chr14 :92246266-92333880 at 14q32.12.
Gene Name: Tandem C2 Domains, Nuclear
Chromosome: CHR14: 92246266 -92333880
Locus: 14q32.12
Gene Diseases
The TC2N TRIP11 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|